Metraipolis › archive › dc_7a2ef3b43dbc
Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies — Europe PMC PMID:41311387
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41311387
- DOI
- 10.1016/j.apsb.2025.09.024
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T21:52:12.954Z
- SHA-256 of the archived text
b706295b2ca4565fba8b41b681f45d5df5dcebea0fe2ffb58abc7a69d71978fc- Stable URL of this page
https://metraipolis.com/documento/dc_7a2ef3b43dbc
How to cite
Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies — Europe PMC PMID:41311387 — Europe PMC (en), https://europepmc.org/article/MED/41311387 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a2ef3b43dbc (Metraipolis archive dc_7a2ef3b43dbc, sha256 b706295b2ca4565fba8b41b681f45d5df5dcebea0fe2ffb58abc7a69d71978fc)
BibTeX
@misc{dc7a2ef3b43dbc,
title = {Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies — Europe PMC PMID:41311387},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41311387},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a2ef3b43dbc; sha256 b706295b2ca4565fba8b41b681f45d5df5dcebea0fe2ffb58abc7a69d71978fc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41311387. Agents can read the archived copy with the MCP tool read_document.